Literature DB >> 19575355

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.

Danuta Owczarek1, Dorota Cibor, Tomasz Mach.   

Abstract

BACKGROUND: Intestinal microvessels of patients with inflammatory bowel disease (IBD) show microvascular endothelial dysfunction. It may contribute to reduced perfusion, poor ulcer healing, and sustained chronic inflammation. The aim of the study was to assess endothelial dysfunction and oxidative stress markers in patients with IBD.
METHODS: Serum levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) were measured in 31 consecutive patients with ulcerative colitis (UC) and 32 with Crohn's disease (CD). Apparently healthy subjects served as age- and sex-matched controls. Associations between these markers and the disease activity and laboratory variables were evaluated.
RESULTS: ADMA, SDMA, and 8-iso-PGF2alpha levels were increased in the IBD group as compared to the control group and higher in patients with CD than UC (P < 0.05 for all comparisons). Arginine levels were similar in all the groups. In the CD and UC groups ADMA and SDMA showed positive correlation with 8-iso-PGF2alpha (r from 0.47-0.67; P < 0.01 for all comparisons). ADMA and SDMA correlated positively with the CD activity (r = 0.4, P = 0.025; r = 0.4, P = 0.024, respectively) and the 8-iso-PGF2alpha level correlated positively with the UC activity (r = 0.4, P = 0.026).
CONCLUSIONS: This is the first study to show that in patients with IBD there is enhanced ADMA generation that might be associated with oxidative stress, and these effects are more pronounced in the CD group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19575355     DOI: 10.1002/ibd.20994

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  18 in total

Review 1.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

Review 3.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 4.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

Authors:  Dorota Cibor; Renata Domagala-Rodacka; Tomasz Rodacki; Artur Jurczyszyn; Tomasz Mach; Danuta Owczarek
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Lactobacillus rhamnosus GG modifies the metabolome of pathobionts in gnotobiotic mice.

Authors:  Jinhee Kim; Iyshwarya Balasubramanian; Sheila Bandyopadhyay; Ian Nadler; Rajbir Singh; Danielle Harlan; Amanda Bumber; Yuling He; Lee J Kerkhof; Nan Gao; Xiaoyang Su; Ronaldo P Ferraris
Journal:  BMC Microbiol       Date:  2021-06-03       Impact factor: 3.605

6.  Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.

Authors:  Daniela Leonetti; Jean-Marie Reimund; Angela Tesse; Stéphanie Viennot; Maria Carmen Martinez; Anne-Laure Bretagne; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

7.  A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients.

Authors:  Amrollah Sharifi; Mohammad Javad Hosseinzadeh-Attar; Homayoon Vahedi; Saharnaz Nedjat
Journal:  Saudi J Gastroenterol       Date:  2016 Jul-Aug       Impact factor: 2.485

8.  Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease.

Authors:  J A Hall; M Yerramilli; E Obare; M Yerramilli; K Almes; D E Jewell
Journal:  J Vet Intern Med       Date:  2016-04-22       Impact factor: 3.333

9.  Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.

Authors:  Maria Giovanna Scioli; Maria Antonietta Stasi; Daniela Passeri; Elena Doldo; Gaetana Costanza; Roberto Camerini; Paolo Fociani; Gaetano Arcuri; Katia Lombardo; Silvia Pace; Franco Borsini; Augusto Orlandi
Journal:  Clin Transl Gastroenterol       Date:  2014-03-20       Impact factor: 4.488

10.  Relationship between lean body mass and serum renal biomarkers in healthy dogs.

Authors:  Jean A Hall; Maha Yerramilli; Edward Obare; Murthy Yerramilli; Lynda D Melendez; Dennis E Jewell
Journal:  J Vet Intern Med       Date:  2015-04-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.